QualityStocksNewsBreaks – Kaival Brands Innovations Group Inc. (KAVL) Leveraging Patented Science to Create Unique Products
Kaival Brands (OTCQB: KAVL), a company focused on developing products into mature, dominant brands, has turned its attention to a new space through acquisition of a patent covering the creation of all synthetic nicotine smoking cessation and synthetic nicotine addiction therapy products. The company’s newly created and wholly owned subsidiary — Kaival Labs — will own the patent and develop associated products. “The science behind these patents has discovered that within the nicotine molecule, the S-isomers control the addictive properties, whereas the R-isomers control the beneficial qualities of the nicotine that a user enjoys,” said Kaival Brands CEO Niraj Patel.…